BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 30511802)

  • 1. Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Guedeney P; Tchétché D; Petronio AS; Mehilli J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Iadanza A; Sardella G; Van Mieghem NM; Sorrentino S; Claessen BEPM; Chandrasekhar J; Vogel B; Kalkman DN; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Ferrer-Grazia MC; Naber C; Kievit P; Baber U; Sharma S; Morice MC; Chieffo A; Mehran R;
    Catheter Cardiovasc Interv; 2019 May; 93(6):1124-1131. PubMed ID: 30511802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.
    Baumbach H; Schairer ER; Wachter K; Rustenbach C; Ahad S; Stan A; Hill S; Bramlage P; Franke UFW; Schäufele T
    BMC Cardiovasc Disord; 2019 May; 19(1):108. PubMed ID: 31088373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.
    Spaziano M; Chieffo A; Watanabe Y; Chandrasekhar J; Sartori S; Lefèvre T; Petronio AS; Presbitero P; Tchetche D; Iadanza A; Van Mieghem NM; Mehilli J; Mehran R; Morice MC;
    J Cardiovasc Comput Tomogr; 2018; 12(4):338-343. PubMed ID: 29735255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
    Bandyopadhyay D; Sartori S; Baber U; Cao D; Chandiramani R; Tchétché D; Petronio AS; Mehilli J; Lefèvre T; Presbitero P; Capranzaro P; Sardella G; Van Mieghem NM; Chandrasekhar J; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Naber C; Kini A; Morice MC; Claessen BE; Chieffo A; Mehran R
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):198-207. PubMed ID: 31977142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Li J; Patel SM; Nadeem F; Thakker P; Al-Kindi S; Thomas R; Makani A; Hornick JM; Patel T; Lipinski J; Ichibori Y; Davis A; Markowitz AH; Bezerra HG; Simon DI; Costa MA; Kalra A; Attizzani GF
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):545-552. PubMed ID: 30312990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement.
    Stephan T; Thoma E; Rattka M; Felbel D; Buckert D; Rottbauer W; Gonska B; Markovic S
    BMC Cardiovasc Disord; 2021 Nov; 21(1):568. PubMed ID: 34847875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Complex Coronary Artery Disease.
    Alperi A; Mohammadi S; Campelo-Parada F; Munoz-Garcia E; Nombela-Franco L; Faroux L; Veiga G; Serra V; Fischer Q; Pascual I; Asmarats L; Gutiérrez E; Regueiro A; Vilalta V; Ribeiro HB; Matta A; Munoz-Garcia A; Armijo G; Metz D; De la Torre Hernandez JM; Rodenas-Alesina E; Urena M; Moris C; Arzamendi D; Perez-Fuentes P; Fernandez-Nofrerias E; Campanha-Borges DC; Mesnier J; Voisine P; Dumont E; Kalavrouziotis D; Rodés-Cabau J
    JACC Cardiovasc Interv; 2021 Nov; 14(22):2490-2499. PubMed ID: 34794656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.
    Saia F; Palmerini T; Compagnone M; Battistini P; Moretti C; Taglieri N; Marcelli C; Bruno AG; Ghetti G; Corsini A; Bacchi Reggiani ML; Marrozzini C; Rapezzi C
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):19-27. PubMed ID: 30916884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Coronary Intervention of Complex Calcific Coronary Lesions Utilizing Orbital Atherectomy Prior to Transcatheter Aortic Valve Replacement.
    Beohar N; Mohammed N; Kherada N; Igyarto Z; Martinsen BJ
    Cardiovasc Revasc Med; 2022 Apr; 37():82-85. PubMed ID: 34261617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Millan-Iturbe O; Sawaya FJ; Lønborg J; Chow DHF; Bieliauskas G; Engstrøm T; Søndergaard L; De Backer O
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):818-826. PubMed ID: 29214718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Huczek Z; Zbroński K; Grodecki K; Scisło P; Rymuza B; Kochman J; Dąbrowski M; Witkowski A; Wojakowski W; Parma R; Ochała A; Grygier M; Olasińska-Wiśniewska A; Araszkiewicz A; Jagielak D; Ciećwierz D; Puchta D; Paczwa K; Filipiak KJ; Wilimski R; Zembala M; Opolski G
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):115-123. PubMed ID: 28843025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic valve calcification as a risk factor for major complications and reduced survival after transcatheter replacement.
    Pollari F; Hitzl W; Vogt F; Cuomo M; Schwab J; Söhn C; Kalisnik JM; Langhammer C; Bertsch T; Fischlein T; Pfeiffer S
    J Cardiovasc Comput Tomogr; 2020; 14(4):307-313. PubMed ID: 31874792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
    Ferrera C; Nombela-Franco L; Garcia E; Jimenez-Quevedo P; Biagioni C; Gonzalo N; Nuñez-Gil I; Viana-Tejedor A; Salinas P; Alberto de Agustin J; Almeria C; Islas F; Perez de Isla L; Fernandez-Perez C; Escaned J; Fernández-Ortiz A; Macaya C
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):809-816. PubMed ID: 27515377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic review and meta-analysis.
    Kotronias RA; Bray JH; Scarsini R; Rajasundaram S; Terentes-Printzios D; De Maria GL; Kharbanda RK; Mamas MA; Bagur R; Banning AP
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):1113-1125. PubMed ID: 32662594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry.
    Puymirat E; Didier R; Eltchaninoff H; Lung B; Collet JP; Himbert D; Durand E; Leguerrier A; Leprince P; Fajadet J; Teiger E; Chevreul K; Lièvre M; Tchetché D; Leclercq F; Chassaing S; Le Breton H; Donzeau-Gouge P; Lefèvre T; Carrié D; Gillard M; Blanchard D
    Clin Cardiol; 2017 Dec; 40(12):1316-1322. PubMed ID: 29247516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials.
    Kleiman NS; Maini BJ; Reardon MJ; Conte J; Katz S; Rajagopal V; Kauten J; Hartman A; McKay R; Hagberg R; Huang J; Popma J;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27601429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and management of coronary artery disease in patients undergoing transcatheter aortic valve replacement.
    Prabhakar M; Liu S; Bagai A; Yanagawa B; Verma S; Cheema AN
    Curr Opin Cardiol; 2020 Sep; 35(5):540-547. PubMed ID: 32649355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.